SCHEMBL20244201

SCHEMBL20244201

CC(=O)N[C@H]1CN(C)C(C(F)F)[C@@H](O)[C@@H]1O

nearest known ligand 0.43

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
OGA O60502 4/20 0.41
HEXA P06865 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18970541 1.00 OGA (0.41) OGAHEXA
SCHEMBL12349947 0.77 OGA (0.44) OGAHEXA
SCHEMBL18970548 0.75 OGA (0.47) OGAHEXA
SCHEMBL13339129 0.73 OGA (0.58) OGAHEXA
SCHEMBL15521182 0.73 OGA (0.58) OGAHEXA
SCHEMBL14426720 0.70 OGA (0.44) OGAHEXA
SCHEMBL25768567 0.70 OGA (0.48) OGAHEXA
SCHEMBL23938021 0.69 OGA (0.37) OGA
SCHEMBL15521171 0.68 OGA (0.45) OGAHEXA
SCHEMBL15521173 0.68 OGA (0.45) OGAHEXA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9994589-B2 Compounds and methods for the treatment of alzheimer's disease and/or cerebral amyloid angiopathy AMICUS THERAPEUTICS, INC. (US) 2018-06-12 US disclosed